- SapuraKencana
Petroleum (SAKP MK) | Results review
- Philippines
Banks | NEUTRAL
- CDL
Hospitality Trusts (CDREIT SP) | Company update
- Thailand
Hotels | OVERWEIGHT
- Thailand
Healthcare | OVERWEIGHT
|
SapuraKencana Petroleum (SAKP MK)
|
Results within range
|
Share Price: MYR4.30 | Target Price: MYR5.30 (+23%) |
MCap (USD): 7.8B | ADTV (USD): 12.3M
|
- FY14
results meet expectations, accounting for 103%/ 95% of our /
consensus full-year forecasts.
- Newfield
Malaysia, consolidated from Feb 14, will drive group earnings:
MYR116m in FY15 and MYR447m in FY16.
- Maintain
BUY and MYR5.30 SOP TP.
|
Philippines Banks | NEUTRAL
|
Sector update
|
Make way for Tier 2 notes
|
- Metrobank�s new
Basel III-compliant Tier 2 notes priced at 5.375% may encourage
other banks to follow.
- Abundant
domestic liquidity can support banks�
capital requirements. Capital adequacy ratios may increase
70-350bps in the process while net interest income may fall
0.7%-4%.
- Top
picks in the sector are RCB and PNB for upside potential of more
than 20%.
|
CDL Hospitality Trusts (CDREIT SP)
|
FY14 a better year for hospitality
|
Share Price: SGD1.62 | Target Price: SGD1.75 (+8%) |
MCap (USD): 1.2B | ADTV (USD): 1M
|
- Expect
hotel room supply to register 5.7% CAGR over 2013-2015, in line
with demand growth.
- Expect
corporate bookings to be more favourable in 2014 as the USD
strengthens against the SGD.
- Brace
for a tactical recovery this year with the hospitality outlook
turning more positive.
|
Thailand Hotels | OVERWEIGHT
|
Sector update
|
Feedback from KL/SG/HK marketing
|
- The feedback
from our marketing trip was positive on strong Thai tourism
industry prospects. Many investors cautious in price movement
that bound back 14% YTD.
- Most
questions were on: i) occupancy rate recovery; ii) timeframe for
tourists to return to Thailand; iii) chances of success for ERW�s Hop
Inn; iv) Bangkok room supply during 2014-16.
- MINT is
our top BUY; ERW is aggressive BUY on Hop Inn project. HOLD
CENTEL.
|
Thailand Healthcare | OVERWEIGHT
|
Sector update
|
Feedback from KL/SG/HK marketing
|
- We met
more than 60 investors during our marketing trip in Malaysia,
Singapore, and Hong Kong last week. Feedback to our investment
thesis was positive and most agree on the strong long-term
industry outlook. However, market-timing is key to healthcare
investing.
- Most
questions were on: i) operational improvement from political
turmoil and newly opened hospitals; ii) doctor shortages; and
iii) short-term catalysts for the sector.
- BCH is
our contrarian BUY. Also BUY BH. HOLD BGH and CHG.
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.